Pregnancy Outcome and Teriflunomide Treatment Exposure for Relapsing Remitting Multiple Sclerosis A 4 year follow up

被引：0
|
作者：
Karageorgiou, Clementine [1 ]
Kargadou, Altani [2 ]
Giannouli, Ermioni [2 ]
Athanasouli, Asimina [2 ]
Kalamatas, Themistokles [3 ]
机构：
[1] Neurol Inst Athens, Athens, Greece
[2] Med Ctr Athens, Athens, Greece
[3] Gen Anthens Hosp, Athens, Greece
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.359
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis
    Kieseier B.C.
    Benamor M.
    Neurology and Therapy, 2014, 3 (2) : 133 - 138
  • [2] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [3] Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient A case report
    D'Aleo, Giangaetano
    Rifici, Carmela
    Donato, Antonina
    Corallo, Francesco
    Di Cara, Marcella
    Bramanti, Placido
    Sessa, Edoardo
    MEDICINE, 2020, 99 (28) : E21212
  • [4] The Danish experience of teriflunomide treatment in relapsing remitting multiple sclerosis
    Magyari, M.
    Buron, M.
    Illes, Z.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 472 - 472
  • [5] The cost of teriflunomide in the treatment of relapsing- remitting multiple sclerosis
    Millar, J. Alasdair
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1490) : 36 - 41
  • [6] Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
    Lesley J. Scott
    Drugs, 2019, 79 : 875 - 886
  • [7] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: the Chieti experience
    di Ioia, M.
    Travaglini, D.
    Di Tommaso, V.
    Mancinelli, L.
    Pietrolongo, E.
    De Luca, G.
    Farina, D.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 754 - 754
  • [8] Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
    Andrew Chan
    Jérôme de Seze
    Manuel Comabella
    CNS Drugs, 2016, 30 : 41 - 51
  • [9] Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    DRUGS, 2019, 79 (08) : 875 - 886
  • [10] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence
    Bayas, Antonios
    Maeurer, Mathias
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 265 - 274
12345